Cancellation of state registration. Pyrazinamide-Acry®

February 18, 2018
Active substances:
ICD-10:
I.A15-A19.A15    Tuberculosis of respiratory organs, confirmed bacteriologically and histologically
Pyrazinamide-Acry, pyrazinamide, anti-tuberculosis drug, tuberculosis, treatment of tuberculosis

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state registermedicinal products for the medical use of the medicinal product (registration certificate P N002354 / 01 dated December 15, 2008 issued by the Open Joint Stock Company "Chemical-Pharmaceutical Plant" Akrihin ", Russia):

Pyrazinamide-Acry® (trade name of the medicinal product)

Pyrazinamide (international non-proprietary or grouping or chemical name)

tablets, 500 mg (dosage form, dosage)

Joint Stock Company "Chemical-Pharmaceutical Plant"

"AKRIKHIN", Russia 142450, Moscow region, Noginsk district, Staraya Kupavna town, ul. Kirova, 29 (name and address of the location of the manufacturer of the medicinal product)

on the basis of a filing by an authorized legal entity of JSC Akrihin, an application for the cancellation of the state registration of a medicinal product.